EcoDrugPlus

Arachidonate 5-Lipoxygenase-Activating Protein

Ensembl ID : ENSSMAG00000004007
Gene Symbol: ALOX5AP
3 Cross references
200 Possible Orthologues:

Arg8-Vasotocin Receptor-Like

Ensembl ID : ENSSMAG00000022874
Gene Symbol: LOC118291529
2 Cross references
195 Possible Orthologues:

Arginine Vasopressin Receptor 1aa

Ensembl ID : ENSSMAG00000006456
Gene Symbol: AVPR1AA
1 Cross references
170 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSSMAG00000001459
Gene Symbol: AVPR2
1 Cross references
178 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 1-Like

Ensembl ID : ENSSMAG00000018275
Gene Symbol: LOC118284651
2 Cross references
191 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSSMAG00000011833
Gene Symbol: AURKA
2 Cross references
232 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSSMAG00000011168
Gene Symbol: AURKB
2 Cross references
205 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSSMAG00000002705
Gene Symbol: LOC118301488
2 Cross references
192 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSSMAG00000000453
Gene Symbol: BACE1
3 Cross references
218 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSSMAG00000018986
Gene Symbol: BDKRB1
3 Cross references
147 Possible Orthologues:

C-Abl Oncogene 1, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSSMAG00000003144
Gene Symbol: ABL1
2 Cross references
202 Possible Orthologues:

Camp-Specific 3',5'-Cyclic Phosphodiesterase 4b-Like

Ensembl ID : ENSSMAG00000010384
Gene Symbol: LOC118310457
2 Cross references
224 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).